Abstract |
1. This four-week, randomized, double-blind, multicenter study compared the efficacy and safety of adinazolam- SR, at three dosage levels, with placebo. Forty (40) patients were randomized at our site: 10 to adinazolam 30 mg/day, 10 to 60 mg/day, 10 to 90 mg/day, and 10 to placebo. All patients were moderately anxious with Hamilton Anxiety Scale (HAM-A) scores of > or = 21 at baseline. 2. The data were analyzed by pooling the three adinazolam groups and comparing them with the placebo group using t-tests. HAM-A scores decreased significantly more in the pooled adinazolam-SR treatment group than in the placebo group at both Week one (p < .02) and at Week two (p < .01), as well as at endpoint (p < .03). 3. At endpoint the adinazolam-treated group included 8 "responders" (> or = 50% reduction on the baseline HAM-A score) while none of the placebo patients were responders (p < .05). Dose-response effects were evaluated and relationships were not statistically significant. 4. The results indicate that adinazolam-SR was clearly superior to placebo for the treatment of patients suffering from Generalized Anxiety Disorder.
|
Authors | C S Wilcox, P J Ryan, J L Morrissey, J B Cohn, D F DeFrancisco, R D Linden, J F Heiser |
Journal | Progress in neuro-psychopharmacology & biological psychiatry
(Prog Neuropsychopharmacol Biol Psychiatry)
Vol. 18
Issue 6
Pg. 979-93
(Oct 1994)
ISSN: 0278-5846 [Print] England |
PMID | 7824763
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Anxiety Agents
- Antidepressive Agents
- Delayed-Action Preparations
- Benzodiazepines
- adinazolam
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Anxiety Agents
- Antidepressive Agents
(administration & dosage, adverse effects, therapeutic use)
- Anxiety Disorders
(drug therapy, psychology)
- Benzodiazepines
(administration & dosage, adverse effects, therapeutic use)
- Delayed-Action Preparations
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Psychiatric Status Rating Scales
|